Investigational Drug Information for Saredutant
✉ Email this page to a colleague
What is the development status for investigational drug Saredutant?
Saredutant is an investigational drug.
There have been 13 clinical trials for Saredutant.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Anxiety Disorders. The leading clinical trial sponsors are Sanofi and [disabled in preview].
Summary for Saredutant
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,081 |
| WIPO Patent Applications | 336 |
| Japanese Patent Applications | 69 |
| Clinical Trial Progress | Phase 3 (2005-04-01) |
| Vendors | 24 |
Recent Clinical Trials for Saredutant
| Title | Sponsor | Phase |
|---|---|---|
| An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder | Sanofi | Phase 3 |
| An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder | Sanofi | Phase 3 |
| A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression | Sanofi | Phase 3 |
Clinical Trial Summary for Saredutant
Top disease conditions for Saredutant
Top clinical trial sponsors for Saredutant
US Patents for Saredutant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
